12 h after hormone treatment, whereas the protein content increased linearly over the 18 h period. The peak of enzyme activity at 9 h is associated with early S phase of the epithelial cells; the peak at 15 h may be associated with a second S phase or with mitosis. Pretreatment with progesterone for 3 days before injection of oestradiol-1 7, (a treatment which inhibits uterine epithelial DNA synthesis) reduced the oestrogenic stimulation of enzyme activity by 63%; progesterone treatment alone did not stimulate enzyme activity. These data suggest that uterine epithelial 3-hydroxy-3-methylglutaryl-CoA reductase may play an important role in the cell cycle in this tissue.
Oestradiol-1 7,B stimulates uterine growth in the ovariectomized rodent. During this process there is increased synthesis of most lipid classes and mobilization of lipid deposits (Beall, 1972; Nilsson, 1964) . Attention has focused on two areas, the stimulation of phospholipid synthesis, particularly phosphatidylethanolamine, very soon after oestrogen stimulation (Aizawa & Mueller, 1961) , and the mobilization of neutral lipid reserves linked with the oestrogen-dependent process of embryo implantation (Boshier et al., 1981) . In addition, significant changes in the lipid composition of the uterus occur in the oestrus cycle and during the response of the uterus of ovariectomized animals to oestrogen and progesterone treatment (Beall, 1972) . Quantitative analysis has shown that, in the mouse, 27% of uterine lipid is cholesterol, and its esterification changes during the oestrus cycle (Goswami et al., 1963) . Further, increased uterine biosynthesis of cholesterol, as measured by the Abbreviation used: glutaryl-coenzyme A. Vol. 218 incorporation of [1-14C] acetate in vivo, has also been reported after oestrogen stimulation (Emmelot & Bosch, 1954) .
Recently the cholesterol biosynthetic pathway, and in particular activity of the rate-limiting enzyme, HMG-CoA reductase (EC 1.1.1.34), has been shown to be intimately linked with the cell cycle of synchronized cultured cells (Brown & Goldstein, 1980) . Inhibition of this enzyme results in an inhibition of DNA synthesis and/or mitosis in a number of cell types (Cornell et al., 1977; Kandutsch & Chen, 1977 and a high degree of synchrony (Martin, 1980 Treatment of animals Female Quackenbush mice, obtained from the Central Animal Breeding House of the University of Queensland, were maintained on 12 h light: 12h dark cycle before use. The animals were ovariectomized when 5-6 weeks old as described by Martin & Finn (1978) , and used 2-3 weeks later. Ovariectomized animals were 'primed' by administration of 200ng of oestradiol-1 7fl/ml of drinking water for 3 days, 5 days before the start of each experiment.
Oestradiol-177# (lOOng in 0.05 ml of arachis oil) was injected subcutaneously, and the animals were killed by cervical dislocation up to 18 h later. Control animals received oil only.
Animals to be treated with progesterone were 'primed' with oestrogen in the drinking water for 3 days as described above, rested for 2 days and then given 1 mg of progesterone in 0.05 ml of arachis oil subcutaneously each day for 3 days. A single injection of oestradiol-17,B (lOOng in 0.05ml of arachis oil) was given subcutaneously at the same time as the last injection of progesterone.
Preparation of mouse uterine tissue extracts
The uterine luminal epithelial cells were removed with a tissue purity of about 80% by the method of Fagg et al. (1979) . The uterine horns from groups of 10 animals were opened longitudinally in situ, dissected free of mesenteric fat and placed into a buffer consisting of 0.1 M-sucrose/50mM-KCI/30mM-disodium EDTA/lOmMpotassium phospl4ate/5mM-dithiothreitol, pH7.6.
Four uterine horns were shaken vigorously in a round-bottomed glass tube with five glass beads (5mm diameter) for 2min in 1 ml of buffer using a vortex shaker. The residual tissues (stroma, myometrium and glands) were removed and replaced by four more horns. The process was repeated so that up to 20 uterine horns were processed into I ml of buffer. Unbroken cells and large sheets of membranes were disrupted by hand hpmogenization in a 10ml Teflon/glass Potter-Elvehjem homogenizer. Before centrifugation tlhe homogenate was diluted to 2ml with buffer. Removal of the luminal epithelium was monitored by routine histology of the residues.
The extracts were centrifuged at 105000g for 60min. To obtain the particulate fraction the pellet was resuspended in 1 ml of buffer by gentle homogenization with a Teflon/glass Potter-Elvehjem homogenizer. In some experiments, the homogenate was first centrifuged at 600g for 10min and then at 15000g for 20min before the 10500Og centrifugation. The pellets from these centrifugations were resuspended in 0.35ml of buffer with the Teflon/glass homogenizer as above. acid lactone (18 uCi/mmol) (0.01 ml of 0.23M) was added to monitor the efficiency of extraction of the product. The entire reaction mix was poured onto a strip of Whatman 3MM chromatography paper and thoroughly dried in an oven at 60°C for 15 min. The product was eluted overnight, directly into scintillation vials, with toluene containing 2,5-diphenyloxazole (5 g/l) and 1,4-bis-(5-phenyloxazol-2-yl) benzene (50mg/1), and 14C and 3H were determined in a liquid-scintillation counter. Duplicate blanks without nucleotide mix were used throughout to monitor and correct for the activity of an HMG-CoA-utilizing enzyme as previously reported for rat liver by Ness & Moffler (1979) . Specific activity of the HMG-CoA reductase is expressed as nmol of mevalonate formed/ min per mg of protein corrected for incorporation in blank assays.
Assay of HMG-

Determination of Km and Vmax
Groups of 10 animals were killed 18h after oestrogen stimulation and uterine epithelial HMGCoA reductase was assayed in quadruplicate over the range of D-HMG-CoA concentration 1-1IOM.
Hyperbolic plots were analysed by non-linear regression as described by Duggleby (1981) .
Determination of protein and DNA Protein was measured by the method of Lowry et al. (1951) with corrections for dithiothreitol in the samples. DNA was measured by the method of LaBarca & Paigen (1980).
Results
Initial characterization of the enzyme
In initial experiments to characterize HMGCoA reductase activity in the uterine luminal epithelium, ovariectomized animals were killed 18h after administration of lOOng of oestradiol and a total particulate fraction was isolated by centrifugation at 105OO0g as described in the Materials and methods section. Production of mevalonate was linear up to a protein concentration of 280ug/assay and linear with time up to 60min. We found little enzyme activity in the uterine epithelium from untreated ovariectomized animals, but noted that activity increased markedly 18 h after subcutaneous administration of lOOng of oestradiol-17/7 (control, 0.018 +0.0035nmol of product/min per mg of protein; oestrogen-stimulated, 0.201 + 0.025 nmol of product/min per mg of protein; means+S.E.M. for four experiments with groups of 10 mice; P<0.02).
The In an attempt to localize this activity within the uterine epithelial cell, a crude subcellular fractionation was achieved by differential centrifugation. High levels of activity were found in all the particulate fractions (Table 1) with minimal activity in the cytosol. The small amount of material available made characterization (particularly for cross-contamination) of these fractions impossible. In subsequent experiments the total particulate fraction was used for assays of enzyme activity. We attempted to characterize the enzyme in the uterine residual tissues. However, because of myofibrillar contamination, we were unable to isolate a fraction comparable with the epithelial particulate fraction. Even so we ascertained that the total activity of the residue represented 56% of the total oestrogen-stimulable uterine activity.
Since the residual tissues contain 90% of the cells of the uterus (Martin et al., 1973b) , the enzymic activity of this fraction on a per cell basis is no more than 10% of that of the luminal epithelial cells.
In our initial experiments we detected a high level of an HMG-CoA-utilizing enzyme. Such an enzyme has been reported in rat liver microsomal extracts by Ness & Moffler (1979) . This enzyme also utilizes HMG-CoA as substrate and produces an as yet unidentified product that co-elutes with mevalonic acid lactone in some conditions, but can be distinguished in others [e.g. chromatography on Bio-Rad AGI X8 (formate) column]. In contrast with HMG-CoA reductase, which requires NADPH for its activity, the HMG-CoA-utilizing enzyme is active in the absence of the nucleotide and inhibited by its presence. Consequently the activity of the utilizing enzyme can be detected and monitored in the absence of nucleotide mix. We found that much of the activity of this enzyme could be removed from epithelial preparations by dilution of the homogenate before centrifugation. Activity was also reduced by preincubation of the extract for 15 min in the presence of nucleotide as described by Ness & Moffler (1979) . We further monitored for residual activity as described in the Materials and methods section.
Time course of hormonal induction of HMG-CoA reductase activity
The time course of changes in uterine epithelial HMG-CoA reductase activity after oestrogenic stimulation is shown in Fig. 1 . The experiment was replicated in its entirety three times. At each time point in each replicate, triplicate estimations of enzyme activity were made on uterine epithelial particulate fractions pooled from groups of 10 mice.
Since overall measured levels of enzyme activity varied significantly from one replicate to another, the values from replicates 2 and 3 were normalized ized data (Table 2) showed that although there was significant between-replicate variation in terms of within-group variability, the pattern of response shown in Fig. 1 was consistent and highly significant. Thus enzyme activity increased linearly from Oh to a peak at 9h (P<O.OO1) without significant quadratic or cubic curvature (Table 2) . Thereafter it fell significantly at 12h (P<O.O1) and subsequently rose to a second peak at 15 h (P<O.O1) falling thereafter to 18h (P<O.O1). In the 18 h following oestrogenic stimulation the total protein and DNA content of the particulate fraction increased by 8-fold and 2-fold respectively (Fig. 2) . Effect of progesterone pretreatment on enzyme activity Treatment ofmice with progesterone prior to the injection of oestradiol-17f results in an inhibition of DNA synthesis in the uterine epithelial cells and the stimulation of division in the cells of the stromal layer (Martin et al., 1973b) . Table 3 shows the effect of pretreatment with progesterone on the stimulation of enzyme activity by oestradiol-17,B.
In the uterine epithelial cells, progesterone pretreatment reduced enzyme activity to 37% of the oestrogen-treated control, while treatment with progesterone alone failed to stimulate enzyme activity.
Discussion
The results reported above are the first investigations of HMG-CoA reductase in uterine epithelial cells. The enzyme activity is stimulated by oestradiol and within the epithelial cell, is associated with the particulate fraction. In hepatocytes it is Table 2 . Analysis of variance of the data in Figure I ** and ***, P < 0.01 and 0.001 respectively, tested against between-group variability; tttP < 0.001 tested against within-group variability. considered that HMG-CoA reductase is a microsomal enzyme. Bell et al. (1976) reported that in HTC cells, enzyme activity was associated with the low-speed pellet as well as the high-speed (lOOOOOg) fraction. However they were unable to state whether this distribution was a feature of HTC cells or reflected an inability to isolate pure subcellular fractions from them. Ih intestinal cells the original finding that much of the HMG-CoA reductase activity was located in the mitochondrial fraction has been challenged and present evidence indicates that the enzyme is of microsomal origin (Field et al., 1982) . In the uterine epithelial cell we find activity in the non-microsomal fractions. However since we were unable to characterize fully these fractions, because of the small yield, the spread of activity may result from contamination with endoplasmic reticulum.
The Km of D-HMG-CoA for the uterine enzyme is similar to the Km of the rat liver enzytne (3.5 pM) recently reported by Gregg (1983) using similar hethods of estimation and within the lower range
Qf the estimates of the Km for liver enzyme (1.01-27.uM) reported by other authors (Langdon & Counsell, 1976; Shapiro & Rodwell, 1971 ).
The data displayed in Fig. 2 Fig. 1 indicates that the first peak of enzyme activity is associated with early S phase. This increase in HMG-CoA reductase may be analogous to the peak of enzyme activity which is associated with early S phase in synchronized BHK-21 cells (Quesney-Huneeus et al., 1979) , and in platelet-derived-growth-factor-stimulated smooth muscle cells (Habernicht et al., 1980) . Brown & Goldstein (1980) concluded that one function of HMG-CoA reductase was to supply a non-sterol derivative of mevalonic acid necessary for the S phase of the cell cycle. Recently QuesneyHuneeus et al. (1983) showed that cells were blocked at two distinct stages of the cell cycle, i.e.
early GI and GI/S, when squalene and mevalonate production respectively were inhibited. It is tempting to suggest that the pre-S phase increase in HMG-CoA reductase serves a similar function in the uterine epithelial cell, supplying compounds required for completion of the G1/S phase of the cell cycle. The function of the second peak is less clear. It has been argued that continued HMG-CoA reductase activity is also required for mitosis, presumably for the provision of cholesterol for new membranes (Gregg & Wilce, 1983) . The peak of activity at 15 h after hormone treatment would coincide with increasing mitosis in these cells. However, Martin et al. (1973a) noted that oestrogen-stimulated cells enter a second round of replication over this period. It is therefore conceivable that the second peak of HMG-CoA reductase activity may be associated with this second S-phase.
Progesterone treatment of the animal results in two major changes in the response of uterine cells to oestrogen stimulation. In the epithelium, oestrogen-stimulated cell division is inhibited, whilst cell division in the connective tissue stroma is increased (Martin et al., 1973b) . In addition, progesterone treatment alone results in differentiation of the epithelial layer and an associated deposition of lipid in the cells (Martin & Finn, 1978) . We have examined HMG-CoA reductase under these conditions. Progesterone pretreatment causes a marked inhibition of the oestrogen-stimulated increase in HMG-CoA reductase in the epithelial cells, but progesterone treatment alone had no effect. It would appear then that the stimulation of HMG-CoA reductase in the uterine epithelium is oestrogen-specific and may be associated with proliferation of the epithelial cells.
In conclusion, it would appear from these data that epithelial cell HMG-CoA reductase is particularly sensitive to oestrogen stimulation, increasing over and above the well-characterized increase in protein content of the cells (a 9-fold increase in enzyme activity compared with a 2-fold increase in particulate fraction protein at 9h; Fig. 2) . We suggest that the data presented here are consistent with a link between this enzyme and the early phases of the cell cycle. Further work will be necessary to elucidate the time course of synthesis of other lipid classes and the relationship of HMGCoA reductase and cholesterol biosynthesis to this time course.
